Search Results 1691-1700 of 202760 for Treatment

  1. Using photon-counting CT to guide treatment for conductive hearing loss - Mayo Clinic

    ... evaluation of middle ear structures. This advanced modality supports more-accurate diagnosis and treatment planning for conductive hearing loss.

  2. Study of Pazopanib in the Treatment of Surgically Unresectable or Metastatic Chondrosarcoma - Mayo Clinic

    Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines ...

  3. Light Treatment Effectiveness (LITE) Study (LITE) - Mayo Clinic

    The purpose of this study is to compare the effectiveness, safety (tolerability), and duration of treatment response at 12 weeks of home versus office-based ...

  4. Julian Rechberger, M.D.: Improving Treatment of Deadly Pediatric Brain Tumors - Student Research - Mayo Clinic College of Medicine & Science

    Julian Rechberger, M.D., student at Mayo Clinic Graduate School of Biomedical Sciences, researched how to improve the treatment of deadly pediatric brain ...

  5. ECOSPOR III - SER-109 Versus Placebo in the Treatment of Adults With Recurrent Clostridium Difficile Infection - Mayo Clinic

    About this study. Subjects will receive an oral dose of SER-109 in 4 capsules once daily for 3 consecutive days in Treatment Group I or matching placebo ...

  6. New year, new focus on health: Mayo Clinic expert highlights effective treatment options for obesity (VIDEO)

    Because it is a complex disease, it requires a comprehensive treatment. Metabolic surgery helps treat obesity in ways other treatments cannot." Addressing ...

  7. Ixekizumab in the Treatment of Bullous Pemphigoid - Mayo Clinic

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

  8. Treatment of Proteinuria Due to Treatment Resistant or Treatment Intolerant Idiopathic FSGS - Mayo Clinic

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

  9. ACP-196 in Combination With Pembrolizumab, for Treatment of Hematologic Malignancies - Mayo Clinic

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

  10. Vedolizumab IV 300 Mg In The Treatment Of Fistulizing Crohn's Disease - Mayo Clinic

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...